article thumbnail

5-Year Safety Data Leaves Investigators Optimistic in Upadacitinib for AD Management

Dermatology Times

Christopher Bunick, MD, PhD, presented the research during a late-breaking research session during the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Safety 74
article thumbnail

Fenbendazole Joe Tippens Protocol: A Simple Step-by-Step Guide (2023)

Aesthetics Advisor

Since fenbendazole is a veterinary medicine, and is not licensed for human use and there is no specific human safety data available. The similar human forms of this class of medications, mebendazole and albendazole, have been used for parasitic infections for many years and have a good safety record. chemotherapy?

Therapy 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASDSA Calls on States to Protect Patients from Counterfeit Neurotoxins

The Dermatology Digest

Recent cases where possibly counterfeit neurotoxins in Illinois and Tennessee led to a cluster of illnesses resembling Botulism highlight the need to strengthen patient safety through increased oversight of medical care in all settings, according to the American Society for Dermatologic Surgery Association (ASDSA).

Safety 69
article thumbnail

U.S. FDA Approves Bimekizumab-bkzx (Bimzelx, UCB) for HS

The Dermatology Digest

The approval of bimekizumab-bkzx blocker is supported by data from two Phase 3 studies, BE HEARD I and BE HEARD II, which evaluated the efficacy and safety of bimekizumab in the treatment of adults with moderate-to-severe HS. living with moderate-to-severe disease,” says Brindley Brooks, Founder and Executive Director of HS Connect.

Safety 78
article thumbnail

And Then There Were Six…FDA Green Lights Hugel’s Toxin for Glabellar Lines

The Dermatology Digest

.” Coral Gables, FL-based dermatologist Joely Kaufman, MD, adds, “The results from the clinical trials for letibotulinumtoxinA demonstrate efficacy, and a convincing safety profile in the treatment of glabellar lines. Hugel resubmitted its application in October 2022 and was denied approval again in 2023. and Europe.

article thumbnail

7 Best Mouthwashes for COVID-19 according to Evidence (2023)

Aesthetics Advisor

Mouthwash is part of the FLCCC I-PREVENT Protocol Best Mouthwashes for COVID-19 according to evidence for 2023 There are lots of great mouthwashes out there, and this list is by no means complete. We’ve included therapeutic mouthwashes with proven anti-COVID-19 ingredient, you can buy over the counter.

article thumbnail

And the Winners Are…PeDRA Announces 2023 Grant Recipients

The Dermatology Digest

Five investigators have received funding through the 2023 PeDRA Research Grants, Career Bridge Research Grant, Pediatric Alopecia Areata Challenge Grant, and Childhood Eczema Challenge Grant programs. The post And the Winners Are…PeDRA Announces 2023 Grant Recipients appeared first on The Dermatology Digest.